- Asian equities track their global counterparts as Fed tries to placate bears.
- Japan leads the run-up, New Zealand bucks the trend.
- Mixed covid updates, geopolitical fears and light calendar test the bulls.
- US Retail Sales, virus news and US central bankers’ reaction become the key.
Friday so far turns out to be a good day for the Asian traders as regional markets rebound ahead of the European session. Among them, Japan’s Nikkei takes the front seat with over 2.0% gains but New Zealand is an odd one in the lot, despite mild losses.
A 14-month low US Jobless Claims joined the Federal Reserve (Fed) officials’ push for multiple months and more data to assent the reflation fears to help the Wall Street benchmarks print the first positive day of the week on Thursday. The moves gained extra support from the US Centers for Disease Control and Prevention (CDC) mandate suggesting no mask requirement for fully vaccinated people.
However, fears that Japan is up for imposing tougher activity restrictions and include more prefectures to battle the coronavirus (COVID-19), coupled with the fears of Indian covid strain, probed the mood earlier in Asia. Also on the risk-negative side were the geopolitical woes in the Middle East as well as the pre-US data caution amid a light calendar in Asia.
Amid these plays, MSCI’s index of Asia-Pacific shares outside Japan follows S&P 500 Futures while flashing above 0.50% intraday gains by the press time. Further, markets in Australia, Hong Kong, Taiwan and South Korea remained nearly 1.0% up whereas shares in China grew around 1.5% on average.
It’s worth mentioning that New Zealand’s NZX 50 drops 1.14% while writing as odds of the RBNZ rate hikes in May 2020 jumps to nearly 70%. Additionally, Indian markets remain jittery, mildly bid of late, as the government’s claims of covid recovery gain a few accolades.
Amid a light calendar, traders await the US Retail Sales for April, as well as the preliminary readings of the Michigan Consumer Sentiment Index for May.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.